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No studies to date examine predictors of treatment satisfaction following intensive cognitive-
behavioral therapy interventions among adolescents. Given the challenges to treatment 
adherence among adolescents, and the promise intensive interventions hold for providing rapid 
symptom relief and increasing access to care, data examining adolescents’ satisfaction with 
intensive programs are needed. Twenty-four adolescents (ages 12-17) with panic disorder 
received an eight-day intensive cognitive-behavioral therapy intervention. Pre-treatment 
characteristics and clinical outcome variables were examined as predictors of satisfaction at post-
treatment and three-months follow-up. Multiple regression analyses revealed that higher levels of 
overall symptom interference at baseline and greater reductions in agoraphobic fear during 
treatment predicted greater treatment satisfaction at post-treatment. Only satisfaction at post-
treatment significantly predicted treatment satisfaction at follow-up, highlighting the potential 
influence of treatment satisfaction on long-term perceptions of treatment. Considerations for 
fostering treatment satisfaction in the context of intensive interventions are discussed.  
 
Keywords: treatment satisfaction, adolescence, cognitive-behavioral therapy, intensive 
intervention, panic disorder 
  





The assessment of treatment satisfaction following psychotherapy has become of increasing 
interest among mental health providers in the last several decades, a shift that is consistent with a 
larger movement within the mental health field to include clients’ perspectives of their 
experiences in therapy to evaluate and subsequently improve of services [1–3] . Treatment 
satisfaction within the context of psychotherapy research has been defined as the subjective 
appraisal of the processes and outcomes of an intervention by the individual who received or 
experienced it [4] . While treatment satisfaction has been operationalized differently across 
studies, measures of satisfaction often involve an assessment of the following constructs: the 
therapeutic relationship (including perceptions of therapist competence and interpersonal style, 
the presence of interpersonal conflict, and perceptions of therapists’ skills), attitudes towards 
treatment (including perceptions of treatment utility and relevance), treatment expectations and 
the degree to which services match expectations, perceptions of treatment effectiveness and the 
degree to which clients attribute outcomes to the treatment process itself [5–8] . The importance 
of measuring treatment satisfaction as part of routine assessments of psychotherapy services is 
highlighted by the limited construct overlap evidenced by small correlations between measures 
of treatment satisfaction and effectiveness reported across studies [1,9,10] , which point to 
treatment satisfaction as a distinct construct from treatment effectiveness, and one that should be 
assessed in conjunction with more traditional measures of therapy outcomes.  
The role of treatment satisfaction is particularly important for adolescent mental health 
treatment. Adolescence is a developmental period that comes with unique challenges to 
treatment engagement, including striving for independence and differentiation from parents and 
other authority figures, as well as the strong prevalence of caregiver-driven referrals to treatment 
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[3,11] . On average, adolescents report being less satisfied with treatment compared to their 
caregivers [12,13] . Additionally, adolescents who are coerced into treatment report lower levels 
of treatment satisfaction, while those who adopt more active roles in seeking services are 
generally more satisfied [5,14] . In turn, low satisfaction with treatment has been shown to be 
associated with low compliance and increased dropout in both adolescent and adult samples 
[15,16] . A recent meta-analytic review of treatment dropout in child and adolescent mental 
health care reported dropout rates ranging from 16-72% [17] . Given the role that satisfaction 
with treatment might play in promoting adherence, coupled with the well-established association 
between treatment adherence and positive therapeutic outcomes [18] , a better understanding of 
predictors of treatment satisfaction among adolescents is crucial in order to prevent early 
termination from treatment and increase the chances of positive treatment outcomes.  
Unfortunately, there is a relative dearth of studies examining predictors of treatment 
satisfaction among adolescents to date [1,3]. In fact, in a comprehensive review of youth 
psychotherapy outcomes research, Weisz and colleagues [19] reported that only 8% of studies 
(out of a total of 235 studies) included a measure of treatment satisfaction. Studies to date have 
looked at a range of variables that influence treatment satisfaction with mental health services 
among adolescents. In an effort to guide this research, Garland and colleagues [1] developed a 
model to capture the core variables that influence treatment satisfaction with mental healthcare 
among adolescents. These include 1. pre-treatment characteristics (e.g., age, gender, diagnostic 
presentation and severity), 2. treatment and therapist characteristics (e.g., level of therapist 
experience, therapeutic alliance), and 3. clinical outcomes (e.g., changes in symptom severity 
and functional impairment during treatment). This model is consistent with the main constructs 
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examined within the broader treatment satisfaction literature, and serves as a useful template to 
review available data from the adolescent treatment satisfaction literature to date.  
Studies examining the associations between pre-treatment characteristics and treatment 
satisfaction have explored the relationships between treatment satisfaction and demographic 
characteristics, diagnostic status and severity, and treatment expectations. While some studies 
report no associations between demographic variables and satisfaction [5,14], others report small 
associations between ethnicity (white youth report greater satisfaction compared to minority 
youth [1] and age (older adolescents report greater satisfaction compared to younger adolescents) 
[3] . Several studies have reported no effects of gender on treatment satisfaction [1,3,20]. 
Overall, demographic variables do not seem to be strong predictors of treatment satisfaction [3]. 
Research on diagnostic status and severity has found that more severe psychopathology is 
associated with lower levels of treatment satisfaction [5,13]. Data on diagnostic type are mixed, 
with some studies reporting no association between different diagnostic categories (e.g., mood, 
anxiety, and externalizing disorders) and satisfaction [1], while others report that youth with 
disruptive behavior, conduct problems, and major depressive disorders report lower levels of 
satisfaction, and that youth with adjustment disorders are more satisfied with treatment [3,12]. 
Finally, more positive expectations of treatment have been shown to be associated with greater 
levels of treatment satisfaction [5,21].  
Characteristics of the therapist and treatment play a role in clients’ satisfaction with services. 
More years of therapist experience, as well as longer duration of treatment, are associated with 
higher levels of satisfaction among adolescents and their caregivers, although the associations 
between these variables are modest in magnitude [1,5,22]. Finally, data on the relationship 
between satisfaction and clinical outcomes – often operationalized as changes in symptoms and 
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functioning over the course of treatment – are mixed. Several studies report no association 
between changes in symptom or functioning and satisfaction [10,23], while others report small-
to-moderate associations between changes in symptom levels, functional impairment, and 
treatment satisfaction [1,3].  
Overall, the available research on which variables are more strongly associated with 
treatment satisfaction among adolescents offers inconsistent findings. Moreover, while several 
types of variables influence treatment satisfaction (e.g., demographic characteristics, diagnostic 
presentation, therapist and treatment characteristics, clinical outcomes), these variables only 
seem to predict a small proportion of the variance in treatment satisfaction. Additionally, most 
research on youth satisfaction is comprised of cross-sectional studies, which limits our 
understanding of how pre-treatment factors (such as demographics, diagnostic status, symptom 
severity) and change in symptom severity and functioning over the course of treatment 
subsequently influence ratings of satisfaction at the end of treatment [1]. 
Another limitation of the adolescent treatment satisfaction literature is the lack of specific 
reporting on the types of interventions examined (e.g., treatment modalities, therapist 
orientations, treatment formats) [1,3]. In fact, while Garland and colleagues [1] include treatment 
and therapist characteristics as determinants of adolescent satisfaction with treatment in their 
model, the authors do not include the type of therapy as one of those predictors. Notably, one 
study examining correlations between youth satisfaction ratings and different types of mental 
health services found that youths’ overall satisfaction with treatment was most highly correlated 
with their satisfaction with individual therapy compared to any other type of services [13]. Data 
from the adult literature suggests that individuals report greater satisfaction with CBT 
interventions compared to other treatment modalities [24,25], but no studies have replicated this 
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finding among adolescents. Despite this lack of detailed reporting on the specific interventions 
investigated, most studies seem to examine treatment satisfaction within the context of longer-
term psychotherapy services.  
To date, no studies have examined predictors of treatment satisfaction within the context of 
brief (intensive) psychotherapy interventions, especially among adolescents. Short-term intensive 
cognitive-behavioral programs have shown promise in treating a range of disorders among 
children and adolescents (e.g., specific phobias [26]; obsessive-compulsive disorder [27]; social 
phobias [28]; panic disorder and agoraphobia [29,30]). These interventions target many of the 
barriers that families of youth with mental health difficulties face, including geographic distance, 
difficulties with scheduling multiple sessions, and arranging weekly transportation. These 
interventions also provide the opportunity for youth to see faster treatment progress, thus 
enabling families to return to their pre-morbid levels of functioning more quickly [29]. Given the 
short-term nature of these interventions, a comprehensive understanding of which factors might 
influence treatment satisfaction are of particular relevance. Shorter interventions may provide 
less time for therapists and clients to foster a strong therapeutic alliance and increase treatment 
buy-in, thus rendering it crucial for clinicians to capitalize on factors that might improve client 
satisfaction with treatment in order to improve adherence and treatment outcomes.  
The purpose of the present study is to extend the existing adolescent treatment satisfaction 
literature by examining predictors of satisfaction among a sample of adolescents who received an 
eight-day intensive cognitive-behavioral therapy (CBT) intervention. Specifically, the goal of the 
present study is to ground the exploration of predictors within the model proposed by Garland 
and colleagues [1] to examine how 1. fixed pre-treatment factors and 2. clinical outcome 
variables influence adolescents’ satisfaction with treatment following the intensive intervention. 
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While Garland and colleagues [1] propose a third set of variables that influence satisfaction – 
treatment and therapist characteristics – these factors were not included in the present analyses 
given the lack of variability with regards to treatment and therapist variables in this study. 
Consistent with the existing treatment satisfaction literature, variables explored included 
demographic characteristics, baseline ratings of symptom severity and associated impairment, 
changes in symptom and functioning levels over the course of treatment, and overall measures of 
improvement during treatment. This study employs a longitudinal design to explore predictors of 
treatment satisfaction at the end of treatment and three-months following the end of treatment. 
Given the mixed nature of data available on predictors of treatment satisfaction among 
adolescents, this study is exploratory and no a-priori hypotheses were proposed. To our 
knowledge, this is the first study to examine predictors of treatment satisfaction among 






Adolescents were recruited for a randomized double-blind placebo-controlled trial, to compare 
the effectiveness of an intensive CBT intervention combined with D-Cycloserine to the same 
CBT intervention combined with placebo in treating panic disorder with agoraphobia among 
adolescents. D-Cycloserine (DCS) is a partial N-methyl-d-aspartate-agonist (NMDA) that has 
been hypothesized to aid the extinction of learned fear [31]. A detailed description of study 
procedures, including inclusion and exclusion criteria, recruitment methods and randomization 
procedures, is published elsewhere (masked for review). The Institutional Review Board of the 
university where the study was conducted approved all study procedures. Families were recruited 
from either the waitlist or clinic website at a university-based clinic in New England specialized 
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in the treatment of anxiety and related disorders. Informed consent and assent were obtained 
from all individual participants and their primary caregivers included in the study.  
Adolescents were included in the study if they had a principal diagnosis of DSM-IV 
Panic Disorder with Agoraphobia (PDA), were on a stable dose of psychiatric medication (at 
least one month prior to the assessment) or no medication and had at least one caregiver to 
accompany them to the sessions. Eligible adolescent participants were randomized into either the 
DCS or placebo group. All participants completed the 6-day intensive treatment and 2 days of 
independent practice. In addition, participants received 50 mg of either the DCS or placebo pill 
on all 3 days of their exposure-based therapy sessions (corresponding to days 3 through 5). Study 




The study sample consisted of 24 adolescents between the ages of 12 and 17 years (M=14.5; 
SD=1.77) and their parents. The sample was comprised of 41.7% males and 58.3% females. A 
majority of the sample identified as Non-Hispanic White (95.8%); one participant identified as 
African-American. Three participants (12.5%) reported an income level below $44,000, i.e., 
200% below the established federal poverty guidelines for a household of four people, seven 
participants (29.2%) reported an income level between $45,000 and $100,000, and fourteen 
participants (58.4%) reported an income level above $100,000. Ten participants (41.6%) were on 
a stable dose of a serotonin reuptake inhibitor (SSRI).  
All participants met criteria for a principal diagnosis of DSM-IV Panic Disorder with 
Agoraphobia (PD/A) with a clinical severity rating of 4 or above (M=5.38; SD=0.71) indicating 
moderate-to-severe levels of severity. Clinical severity ratings were derived from information 
about participants’ levels of distress and impairment associated with their symptoms. Diagnostic 
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status was based on reports from both parents and adolescents. Additionally, a majority of 
participants (n=14; 58.3%) met criteria for comorbid disorders, including specific phobias (n=9, 
37.5%), generalized anxiety disorder (n=4, 16.7%), separation anxiety disorder (n=3, 12.5%), 
social anxiety disorder (n=2, 8.3%), major depressive disorder (n=2, 8.3%), depressive disorder 




The intervention consisted of an intensive, 6-day course of individual cognitive behavioral 
therapy for panic disorder and agoraphobia (2-6 hours of treatment each day) with two days of 
independent practice following day 5 of the intervention where participants engaged in 
independent in-vivo exposures. All treatment sessions were conducted by the principal 
investigator (OL), a licensed clinical psychologist with extensive experience with the treatment 
protocol and youth anxiety disorders. Each session focused on a core CBT skill and topics 
included were as follows: psychoeducation about panic disorder and agoraphobia (Day 1), 
cognitive restructuring (Day 2), interoceptive exposures (Day 3), in-vivo exposures in session 
(Days 4-5), independent in-vivo exposures (Days 6-7), relapse prevention (Day 8). The 
intervention also consisted of daily, 30-minute parent training sessions during which therapists 
introduced parents to the skills covered in session that day, as well as parenting strategies aimed 
at helping their adolescents cope with anxiety. For a more detailed description of the intensive 
treatment protocol, please see [29].   
Measures  
 
Measures included in the study were a combination of clinician-rated, parent-report, and self-
report questionnaires. Assessments were conducted at baseline, post-treatment, and at 3-months 
following the end of the treatment by independent evaluators, who were doctoral students in 
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clinical psychology. Two participants dropped out of the study; therefore post and 3-month data 
were only available for 22 out of the 24 participants. The Cronbach’s Alpha values for the self-
reported measures are reported in XXX (masked for review), and were all equal to or greater than 
.70. The following demographic information was collected at baseline for each participant: age, 
gender, race/ethnicity, and household income level.  
 
Anxiety Disorders Interview Schedule for the DSM-IV-Child and Parent Versions (ADIS-IV-
C/P). The ADIS-IV-C/P is a structured interview designed to diagnose anxiety and related 
disorders in children and adolescents, based on DSM-IV criteria [32]. The degree of impairment 
and distress associated with each disorder is captured by a clinical severity rating (CSR) ranging 
from 0 (absence of a diagnosis) to 8 (very severe presentation). A CSR ≥4 is indicative of a 
clinical level of impairment. Agoraphobic fear ratings were computed for each participant by 
summing the fear ratings (on a scale from 0 “no fear” to 8 “very severe fear”) of various 
agoraphobic situations assessed as part of the ADIS-IV-C/P (e.g., crowds, elevators, air travel, 
taking public transportation, leaving the house, being home alone). The ADIS-IV-C/P has 
demonstrated good seven-to-fourteen day test-retest reliability of impairment ratings (r range =  
0.8-0.84 for various anxiety disorder diagnoses) [33]. Of note, recruitment for the study began 
prior to the release of the DSM-5.  In order to remain consistent, the DSM-IV criteria are used 
throughout the trial. Additionally, the ADIS-V-C/P has not been released to date, so the ADIS-
IV-C/P continues to be used in research and clinical practice, adjusting for any changes to 
diagnostic criteria in the DSM-5. 
 
Panic Disorder Severity Scale-Child Version (PDSS-C). The PDSS-C is a self-report measure 
that assess the presence of panic disorder symptomatology and its associated impairments. The 
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scale is comprised of 7-items that assess for the presence and severity of the following: panic 
frequency, panic-related distress, anticipatory anxiety, panic-related avoidance of situations and 
sensations. The PDSS-C has been shown to have strong psychometric properties, including good 
convergent and discriminant validity, sensitivity to treatment-related changes in symptoms, and 
adequate one-day test-retest reliability (r=0.79) [34]. High scores represent more severe levels of 
panic disorder symptoms and associated impairments.  
 
Subjective Symptoms Scale-Child Version (SSS-C). The SSC-C is a 5-item self-report scale 
comprised of ratings of the extent to which anxiety symptoms interfere with given areas of daily 
functioning: school, home management, private leisure, social leisure, and family relationships. 
The SSC-C is a modified version of the Adult Subjective Symptoms Scale for which the areas of 
impairment in daily functioning were altered to be developmentally more appropriate for 
adolescents [35]. High scores represent lower levels of overall interference/impairment. No 
psychometric studies have been conducted to date for the SSS-C. The adult version has shown 
good internal consistency in clinical samples [36]. 
 
Childhood Anxiety Sensitivity Index (CASI). The CASI is an 18-item self-report scale that 
measures how aversely youth view symptoms of anxiety. The measure is an adaptation from the 
Anxiety Sensitivity Index [37] and has shown good psychometric properties in both clinical and 
nonclinical samples, including good convergent, discriminant validity, criterion-related validity, 
and test-retest reliability (using a two-week retest interval, r=0.79 in clinical samples) [38–41]. 
High scores represent higher levels of anxiety sensitivity.   
 
Clinical Global Improvement (CGI-Improvement). The CGI is a 1-item clinician-rated measure 
that captures diagnostic improvement over the course of treatment. The CGI is a well-established 
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measure of improvement in symptoms and functioning during treatment [42], and  has been 
shown to be strongly associated with self-report and clinician-rated measures of anxiety 
symptomatology and impairment [43]. The item ranges from 1 (very much improved) to 7 (very 
much worse).  
 
Perceptions of Treatment Questionnaire-Adolescent Version (POTQ-A). The POTQ-A is a self-
report measure that was developed for use in treatment studies at the university where the study 
was conducted. It is comprised of 17 items that assess the acceptability of treatment, and 
adolescents’ satisfaction with different components of treatment and are rated on a Likert scale 
ranging from 0 (not at all) to 8 (very much). The elements of treatment satisfaction assessed were 
as followed: treatment credibility (e.g., “How much did this treatment make sense to you in 
terms of decreasing anxiety and panic?”), treatment expectancy (e.g., “How much do you think 
the treatment helped you cope with anxiety/panic?”), the helpfulness of specific treatment skills 
(e.g., “How helpful did you find cognitive restructuring for treating your anxiety/panic?”), 
adolescents’ confidence in recommending treatment to others (e.g., “How confident would you 
be in recommending this treatment to a friend with difficulties with anxiety and panic?”), 
perceptions of the therapist and therapeutic alliance (e.g., “How much do you agree with this 
statement: My therapist was supportive?”), planned future skill use (e.g., “How much do you 
think you will use the skills and strategies that you learned in treatment in the future?”), and 
overall quality of life (e.g., “How satisfied are you with your life currently?”). Scores on 
individual items were summed to create a continuous measure of overall satisfaction. Higher 
scores represent higher levels of treatment satisfaction. No psychometric studies have been 
conducted on this measure to date.  
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Data Analytic Strategy  
 
Variables of interest were selected to reflect predictors of treatment satisfaction included in the 
Garland et al. [1] model. The pre-treatment variables included socio-demographic characteristics 
and youth clinical characteristics. The demographic variable of gender was included as a 
dichotomous variable (0=male; 1=female) while participant age was included as a continuous 
variable. Given the relative homogeneity of the study sample with regards to race/ethnicity 
(N=21/22 White), this variable was not included as a predictor in the analyses. Baseline 
characteristic variables included baseline ratings of agoraphobic fear, anxiety sensitivity (CASI), 
panic symptom severity (PDSS-C), baseline symptom interference/functioning (SSS-C), and the 
total number of diagnoses at baseline. Among the clinical outcome variables proposed in the 
model, we included measures of both change in symptoms and change in functional impairment 
over the course of treatment. To this aim, change scores were computed by subtracting the post-
treatment score from the baseline score for each measure. This approach to measuring change in 
clinical outcomes (also referred to as simple gain scores) has been well established in studies 
examining clinical outcomes in youth mental health care [1,10]. While Garland and colleagues 
[1] propose a third set of variables that influence satisfaction – treatment and therapist 
characteristics – these factors were not included in the present analyses given the lack of 
variability with regards to treatment and therapist variables in this study. Treatment for all 
participants was provided by the same therapist (OL), all treatment sessions were conducted per 
the same study protocol (an intensive CBT intervention for panic disorder and agoraphobia, see 
[29]), and all courses of treatment were of the same duration (eight days). The means and 
standard deviations for all continuous measures at each time point are provided in Table 2. 
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In order to examine the amount of variation in treatment satisfaction that is accounted for 
by baseline characteristics and change in clinical outcomes, two sets of analyses were conducted. 
First, zero-order correlations were computed to examine the relationship between each of the 
seven variables of interest and treatment satisfaction at post-treatment and treatment satisfaction 
at 3-months follow-up. Next, variables that were significantly associated with treatment 
satisfaction based on the Pearson correlations were included in multiple regression analyses 
predicting treatment satisfaction at post-treatment and at three-months follow-up to assess for 
unique predictors and total variance accounted for by all predictors combined. Multiple 
regression analyses were conducted separately at each timepoint. Baseline characteristic 
variables were entered in the first step, followed by clinical change variables. This approach to 




Demographic Information  
 
As previously reported in XXX (masked for review), there were no significant differences in 
treatment satisfaction scores between the DCS and placebo groups. As such, both groups were 
combined for the purposes of the analyses. The means and standard deviations for all continuous 
measures at each time point are provided in Table 1. Age was not significantly correlated with 
treatment satisfaction at post-treatment and follow-up. Paired-samples t-tests were conducted to 
examine whether there were gender differences (males and females) in treatment satisfaction 
levels at post-treatment and follow-up. There were no significant differences in mean treatment 
satisfaction levels between males and females at post-treatment (t(20)=-.325, p=.748) and 
follow-up (t(20)=.088, p=.931).  
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Relationship Between Baseline Characteristics, Change in Clinical Outcomes, and Treatment 
Satisfaction at Post-Treatment  
 
Correlations between baseline characteristics and treatment satisfaction. The Pearson’s 
correlations for each predictor variable with treatment satisfaction at post-treatment are presented 
in Table 2. At baseline, higher levels of symptoms interference/impairment were moderately (r=-
.476) associated with higher levels of treatment satisfaction at post-treatment. Additionally, 
higher baseline levels of agoraphobic fear were moderately (r=.474) associated with higher 
levels of treatment satisfaction at post-treatment. None of the other baseline characteristics were 
significantly associated with treatment satisfaction at post-treatment.  
 
Correlations between clinical change variables and treatment satisfaction. Among the clinical 
change variables, greater reductions in the number of total diagnoses from pre- to post-treatment, 
as well as greater reductions in the level of agoraphobic fear were significantly and strongly 
(r=.514 and r=.518, respectively) associated with higher treatment satisfaction at post-treatment. 
None of the other clinical change variables were significantly associated with treatment 
satisfaction at post-treatment. Given the method used to calculate change scores, the baseline 
levels of agoraphobic fear and the change in agoraphobic fear variables were highly correlated 
(r=.717, p<.001) and thus could not be included in the same regression model. For this reason, 
we decided to omit the baseline level of agoraphobic fear variable from the final regression 
model.  
 
Predicting treatment satisfaction from baseline characteristics and clinical change variables. 
Results of the regression indicated that overall level of symptom interference at baseline 
accounted for 18.8% of the variance in treatment satisfaction at post treatment (Table 3). When 
clinical change variables were included in the model (change in total number of diagnoses and 
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change in levels of agoraphobic fear), all variables combined accounted for 56.1% of the 
variance in treatment satisfaction at post-treatment, and this change in R2 was significant (F(3, 
18) =9.476, p<.01). Across both models, higher levels of overall symptom interference at 
baseline was associated with higher levels of treatment satisfaction at post-treatment. Greater 
reductions in the level of agoraphobic fear predicted greater treatment satisfaction at post-
treatment, while reductions in the in the total number of diagnoses was not significantly 
associated with satisfaction.  
 
Relationship Between Baseline Characteristics, Change in Clinical Outcomes, and Treatment 
Satisfaction at Follow-Up  
 
Correlations between baseline characteristics and treatment satisfaction. The Pearson’s 
correlations for each predictor variable with treatment satisfaction at follow-up are also presented 
in Table 2. Higher levels of baseline symptom interference were moderately (r=-.482) associated 
with higher levels of treatment satisfaction at follow-up. Additionally, higher levels of baseline 
agoraphobic fear were moderately (r=.435) associated with higher levels of treatment 
satisfaction at follow-up. None of the other baseline characteristics were significantly associated 
with treatment satisfaction at follow-up. 
 
Correlations between clinical change variables and treatment satisfaction. Among the clinical 
outcome variables, greater reductions in the number of total diagnoses from pre- to post-
treatment were strongly (r=.644) associated with higher treatment satisfaction at follow-up. 
Greater reductions in the level of agoraphobic fear were also moderately (r=.471) associated with 
higher treatment satisfaction at follow-up. Additionally, greater overall clinical improvement was 
strongly (r=-.509) associated with greater levels of treatment satisfaction at follow-up. None of 
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the other clinical change variables were significantly associated with treatment satisfaction at 
follow-up.  
 
Predicting treatment satisfaction from baseline characteristics and clinical change variables. 
Results of the regression indicated that treatment satisfaction at post-treatment accounted for 
83.4% of the variance in treatment satisfaction at follow-up (Table 4). When baseline 
characteristics and clinical change variables (baseline levels of symptom interference, change in 
agoraphobic fear, change in total number of diagnoses, and overall clinical improvement) were 
included in the model, all variables combined accounted for 87.9% of the variance in treatment 
satisfaction at follow-up, and this change in R2 was significant (F(5, 16)=3.61, p<.05). Across all 
models, greater satisfaction at post-treatment was associated with higher levels of treatment 
satisfaction at follow-up. However, when controlling for satisfaction at post-treatment, none of 
the baseline characteristic variables and clinical change variables were significantly associated 




This study is the first to examine predictors of treatment satisfaction within the context of an 
intensive, cognitive-behavioral treatment for adolescents with panic disorder and agoraphobia. 
Given the short-term nature of intensive interventions, therapists might need to capitalize on 
factors that improve adolescent satisfaction with treatment to foster a therapeutic alliance and 
improve treatment adherence within a short time-frame. The exploration of predictors of 
satisfaction in this study were grounded within the Garland and colleagues [1] model that 
proposes three categories of predictors: 1. fixed pre-treatment variables, 2. clinical outcome 
variables, and 3. treatment and therapist characteristics. For the purposes of this study, we 
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focused on the first two categories of predictors at two time points: the end of treatment, and 
three-months following the end of treatment, as treatment and therapist characterstics remained 
constant throughout the study.  
 Consistent with the broader treatment satisfaction literature [3], demographic 
characteristics (i.e., age, gender) were not associated with treatment satisfaction at either time 
point. However, this finding should be considered in light of the study’s relatively homogenous 
sample (e.g., almost entirely white), such that participant race/ethnicity was not examined as a 
predictor of satisfaction. Given some preliminary evidence that ethnicity might be related to 
satisfaction [1], studies with more diverse samples are needed to clarify the role race and 
ethnicity might play in adolescents’ experiences of intensive treatment.  
Among the baseline youth clinical characteristics, participants’ level of overall symptom 
impairment/interference was a significant predictor of treatment satisfaction at the end of the 
intervention, such that adolescents with higher levels of impairment at baseline reported higher 
levels of satisfaction. This finding contradicts the broader treatment satisfaction literature, which 
reports that more severe manifestations of pathology are associated with lower levels of 
treatment satisfaction [1,13]. High overall symptom impairment at baseline might set the stage 
for greater room for change, and change might occur at a quicker rate within the context of an 
intensive intervention, thus increasing the perceived effectiveness of treatment. Additionally, 
changes in clinical outcomes over the course of treatment contributed to treatment satisfaction 
over and above the effects of baseline psychopathology severity. More specifically, greater 
reductions in adolescents’ levels of agoraphobic fear – a central component of their diagnostic 
profiles – was a significant predictor of treatment satisfaction at post-treatment when controlling 
for baseline symptom interference. While evidence of the influence of clinical outcomes on 
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satisfaction is mixed, our findings are in line with some of the research that reports small-to-
moderate associations between treatment satisfaction and changes in overall functioning and 
symptom severity [3]. It would appear that changes in one of the core components of 
adolescents’ clinical presentation (i.e., the severity of their agoraphobic symptoms) is a key 
factor that influences satisfaction with treatment, over and above broader measures of 
functioning or impairment. Our finding that changes in the total number of diagnoses from pre- 
to post-treatment did not predict treatment satisfaction might be explained by the relatively small 
range in number of diagnoses assigned at baseline (ranging from 1 to 6, M(SD)=2.08(1.32)) thus 
leaving little room for change over the course of treatment. While individuals who demonstrated 
a greater decrease in their total number of diagnoses did report higher levels of satisfaction with 
treatment, this effect was no longer significant when combined with other variables to predict 
satisfaction. It would appear that the predictive value of baseline interference levels and changes 
in agoraphobic fear during treatment were more significant predictors of satisfaction with 
treatment, over and above the effect of decreases in the number of diagnoses for which the 
participants met criteria.  
Taken together, baseline levels of symptom interference and changes in agoraphobic fear 
levels of the course of treatment accounted for a little over half of the variance in treatment 
satisfaction at the end of treatment. This is a higher overall model R2 than is reported in other 
studies examining predictors of treatment satisfaction in adolescents, with total variances 
explained ranging from 2% to 33.8% [1,3,5]. These findings regarding the important impact of 
clinical change variables on treatment satisfaction raise an interesting question about the 
influence of the timing of change on clients’ satisfaction with treatment. Presumably, changes in 
symptom levels and overall impairment/functioning would occur earlier in treatment, or unfold 
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as a faster rate, in the context of intensive interventions as compared to longer-term 
psychotherapy. Could earlier improvements in symptoms and functioning, or improvements at a 
quicker rate, be associated with higher levels of satisfaction at the end of treatment? There is 
some literature to suggest that the timing of therapeutic gains over the course of treatment is 
associated with treatment adherence among CBT interventions for adults [44], but little research 
has been conducted on treatment satisfaction. It is possible that intensive interventions might be 
associated with higher levels of treatment satisfaction overall, given their focused nature and 
their potential to engender rapid symptom change. Future research should examine the impact of 
the timing and rate of change on treatment satisfaction during interventions of varying durations 
and across populations.  
 In addition to examining predictors of treatment satisfaction at the end of treatment, we 
explored whether treatment satisfaction was maintained in the months following the end of the 
intervention, and what factors might contribute to treatment satisfaction at follow-up. Longer-
term perceptions of treatment might play an important role in future treatment seeking behaviors. 
In fact, there is some evidence from the adolescent and young adult literature to suggest that 
prior positive experience with mental health treatment is associated with future help-seeking 
behaviors [45]. This is especially important among adolescents as they transition into young 
adulthood given the low levels of treatment seeking that are commonplace among this age group 
[46,47]. To our knowledge, this is one of few studies that extend the examination of predictors of 
satisfaction to several months following the end of treatment [3]. Our findings revealed that the 
single strongest predictor of treatment satisfaction at follow-up (which accounted for 83.4% of 
the variance in satisfaction) was treatment satisfaction at the end of treatment. While several 
other factors were associated with satisfaction at follow-up (including baseline levels of 
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agoraphobic fear and overall symptom interference, changes in agoraphobic fear, total number of 
diagnoses, and overall clinical improvement during treatment), none of these variables 
significantly predicted satisfaction at follow-up when post-treatment satisfaction was included in 
the model. Nonetheless, these findings speak to the importance of fostering high levels of 
treatment satisfaction at the end of treatment, as this seems to influence continued perceptions of 
treatment following the end of therapy.  
Several implications for clinicians who are trying to increase treatment satisfaction 
among their clients can be inferred from our findings. First, our findings highlight the importance 
of symptom improvement during treatment in determining adolescents’ satsisfaction with 
services. Clinicians might benefit from highlighting clients’ progress during treatment and 
helping clients focus on the gains they have made to promote greater satisfaction. This could be 
achieved through the use of routine outcome monitoring or in-session use of reflection strategies 
that higlight progress. Clinicians might also help clients set small, attainable treatment goals in 
order to foster a sense of progress and achievement in sessions. Additionally, the focus on 
progress and treatment gains might be especially important to implement among individuals who 
may be prone to lower satisfaction with treatment from the start. Our findings suggest that 
individuals with lower levels of symptoms interference and impairment at baseline are less 
satisfied with treatment, and so clinicians might want to pay particular attention to changes in 
symptoms and clients’ perceptions of progress among those with who initially present with lower 
levels of symptom severity. Finally, the strong association between satisfaction at the end of 
treatment and at three months follow-up suggests that clients’ end-of-treatment satisfaction could 
have implications for their willingness to seek treatment in the future, thus highlighting the 
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importance of monitoring satisfaction with treatment as a potential predictor of future help-
seeking.   
 The findings from this study should be considered in light of its limitations. First, the 
study’s small and relatively homogenous sample (in terms of participant demographics and 
clinical presentations) might limit the generalizability of results to more diverse samples and 
reduces the ability to detect smaller effects of variables that might influence treatment 
satisfaction. Relative to the general population of adolescents with anxiety disorders, our sample 
was comprised of individuals from higher income backgrounds and included a higher proportion 
of male participants [48]. The generalizability of findings from this study are also limited by 
additional sample characterstics—including the use of SSRIs by just under half of participants—
making it possible that our findings might not generalize to larger samples of adolescents with 
panic disorder who might not be receiving any pharmacotherapy. Furthermore, while there were 
no differences in treatment satisfaction ratings between the DCS and placebo groups, our study 
design might limit the generalizability of findings to samples of adolescents with panic disorder 
who receive intensive CBT without the addition of DCS. Finally, another potential limitation of 
this study is the reliance on DSM-IV criteria to establish diagnoses, given the separation of panic 
disorder and agoraphobia diagnoses in the DSM-5. However, it is important to note that all 
participants in our study met DSM-IV criteria for panic disorder with agoraphobia, and thus it is 
likely that our results would be similarly applicable to adolescents who meet DSM-5 criteria for 
both panic disorder and agoraphobia. Nonetheless, these findings provide a preliminary 
exploration of the variables that influence treatment satisfaction within the context of an 
intensive eight-day intervention, and lays the groundwork for future studies with larger, more 
demographically and clinically diverse samples. Future studies could consider examining 
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whether the use of psychotropic medications in conjunction with psychotherapy influences 
treatment satisfaction among adolescents during psychotherapy interventions.   
Additionally, in light of the lack of variability with regards to treatment and therapist in 
the study, these variables were not examined as potential predictors of treatment satisfaction. As 
mentioned above, treatment for all participants was provided by the same therapist (OL), all 
treatment sessions were conducted per the same study protocol, and all courses of treatment were 
of the same duration. However, prior research has suggested that certain therapist and treatment 
variables, including years of experience and duration of therapy, influence treatment satisfaction 
among adolescents and their caregivers [1,5,22]. An important next step would be to compare the 
influence of different predictors of treatment satisfaction across treatments of varying durations, 
modalities, and therapists’ theoretical orientations. Finally, no data were available to examine 
predictors of caregiver satisfaction with treatment – a construct that has been shown to be 
independent of adolescents’ satisfaction ratings (as reflected by low-to-moderate correlations 
between caregiver and adolescent ratings of treatment satisfaction; [1,3]) as well as an important 
predictor of treatment engagement and adherence [16,49]. Future research should consider 
integrating satisfaction ratings from both caregivers and adolescents to examine predictors of 
satisfaction with treatment for both parties, as well as examine the influence of caregiver 
satisfaction on adolescent satisfaction with treatment. Along this line, future research would 
benefit from examining additional variables that might moderate the relationship between 
baseline characterstics, clinical change variables, and satisfaction with treatment, including 









This is the first study to date to examine predictors of treatment satisfaction among adolescents 
who received an eight-day intensive CBT intervention, and extends the existing adolescent 
treatment satisfaction literature by grounding the exploration of predictors within the model 
proposed by Garland and colleagues [1]. Consistent with the existing literature, our findings 
revealed that both fixed-service entry variables as well as clinical outcome variables influenced 
satisfaction at the end of treatment, however, in our study, these variables contributed to a larger 
proportion of variance in treatment satisfaction than previously reported. More specifically, 
higher baseline levels of overall symptom interference, as well as greater reductions in 
agoraphobic fear over the course of treatment, predicted higher levels of treatment satisfaction 
post-intervention. Three months following the end of treatment, the only significant predictors of 
maintained satisfaction with services was satisfaction with treatment at the end of the week-long 
intervention. These findings provide a preliminary exploration of predictors of satisfaction in the 
context of an intensive treatment, and should be replicated within larger, more diverse clinical 
samples. 
 
Ethical Approval: All procedures performed in studies involving human participants were in 
accordance with the ethical standards of the institutional and or/national research committee and 
with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.   
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Table 1. Means and Standard Deviations of Measures at Baseline, Post-Treatment, and 3MFU 
 






 M (SD) Range M (SD) Range M (SD) Range 
Agoraphobic fear  25.79 (20.39) 0-69 10.18 (15.76) 0-57 5.64 (9.18)  0-28 
Anxiety sensitivity (CASI) 37.79 (6.43) 27-52 31.14 (8.39) 18-48 28.86 (7.53) 18-47 
Panic symptom severity (PDSS-C) 10.92 (4.41) 4-20 5.41 (5.12) 0-19 4.45 (3.86) 0-11 
Overall symptom interference/impairment (SSS-C) 17.17 (8.19) 3-35 8.00 (7.75) 0-27 5.77 (5.57) 0-15 
Total number of diagnoses 2.08 (1.32) 1-6 1.55 (1.47) 1-6 .95 (1.25) 0-4 





























at post r(p) 





     Age -.167 (.458) -.312 (.158) 
     Agoraphobic fear .474 (.026)* .435 (.043)* 
     Anxiety sensitivity (CASI) -.085 (.706) -.221 (.322) 
     Panic symptom severity (PDSS-C) .033 (.883) -.065 (.773) 
     Overall symptom interference/impairment (SSS-C) -.476 (.025)* -.482 (.023)* 
     Total number of diagnoses -.045 (.841) .003 (.990) 
   
Clinical change variables pre-post treatment   
     Agoraphobic fear  .518 (.014)* .471 (.027)* 
     Anxiety sensitivity (CASI) .153 (.497) .055 (.808) 
     Panic symptom severity (PDSS-C) .086 (.703) .095 (.675) 
     Overall symptom interference/impairment (SSS-C) -.128 (.569) -.052 (.818) 
     Total number of diagnoses .514 (.014)* .644 (.001)*** 
     Clinical global improvement (CGI) -.367 (.093) -.509 (.016)* 
 
Note. N=22. *p<.05, **p<.01, ***p≤.001 
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Note. N=22. *p<.05, **p<.01, ***p<.001 
 
  
Predictor Model 1 Model 2 
 B SE β B SE β 
Baseline symptom interference/impairment -.998* 7.661 -.476* -.986** .323 -.471** 
Change in agoraphobic fear _ _ _ .383** .113 .515** 
Change in total number of diagnoses _ _ _ 4.137 2.524 .258 
R2  .188   .561  
R2 change     .397  
F for change in R2  5.863*   9.476**  
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Table 4. Treatment satisfaction at follow-up regressed on baseline characteristic and clinical change variables. 
 
Predictors Model 1 Model 2 Model 3 
 B SE β B SE β B SE β 
Treatment satisfaction at post 1.082*** .105 .918*** 1.049*** .121 .890*** .868*** .146 .736*** 
Baseline symptom 
interference/impairment 
_ _ _ -.144 .254 -.058 -.206 .247 -.083 
Change in agoraphobic fear _ _ _ _ _ _ -.025 .094 -.028 
Change in total number of 
diagnoses 
_ _ _ _ _ _ 3.30 1.767 .175 
Overall clinical improvement _ _ _ _ _ _ -3.672 1.871 -.181 
R2  .834   .829   .879  
R2 change     .003   .063  
F for change in R2  106.865***   .321   3.61*  
Note. N=22. *p<.05, **p<.01, ***p<.001 
 
 
 
 
 
 
